Ajanta Pharma Ltd banner

Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 3 119 INR 2.32% Market Closed
Market Cap: ₹389.7B

Wall Street
Price Targets

AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd

Wall Street analysts forecast AJANTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 3 309.98 INR with a low forecast of 2 631.05 INR and a high forecast of 3 929.1 INR.

Lowest
Price Target
2 631.05 INR
16% Downside
Average
Price Target
3 309.98 INR
6% Upside
Highest
Price Target
3 929.1 INR
26% Upside
Ajanta Pharma Ltd Competitors:
Price Targets
JNJ
Johnson & Johnson
-3% Downside

Revenue
Forecast

16% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

18% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's operating income is 18%. The projected CAGR for the next 3 years is 17%.

Net Income
Forecast

21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's net income is 21%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AJANTPHARM's stock price target?
Price Target
3 309.98 INR

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 3 309.98 INR with a low forecast of 2 631.05 INR and a high forecast of 3 929.1 INR.

What is Ajanta Pharma Ltd's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 14%.

What is Ajanta Pharma Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's operating income is 18%. The projected CAGR for the next 3 years is 17%.

What is Ajanta Pharma Ltd's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Ajanta Pharma Ltd's net income is 21%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett